Key result
Intraplaque microbial biofilms promote inflammation and plaque destabilization, complementing traditional lipid-centric CAD models.
Why the study?
The traditional lipid-driven inflammatory model of atherosclerosis does not fully explain acute coronary events from non-obstructive lesions or the persistence of residual cardiovascular risk despite lipid-lowering therapy.
Answers are grounded in this paper and cite their sources.
This review proposes an integrated model where intraplaque bacterial biofilms act as latent amplifiers of inflammation and plaque rupture, offering a potential explanation for residual cardiovascular risk and acute events in non-obstructive coronary artery disease.
Atherosclerosis is traditionally viewed as a lipid-driven inflammatory disease; however, this model does not fully explain acute coronary events arising from non-obstructive lesions or the persistence of residual cardiovascular risk despite lipid-lowering therapy. Emerging evidence implicates infectious agents as contributors to plaque instability rather than primary initiators of disease. Epidemiological studies demonstrate temporal associations between infections and myocardial infarction, while molecular analyses have identified bacterial components within atherosclerotic plaques. Recent findings suggest that microorganisms exist within plaques as biofilms, structured communities embedded in an extracellular matrix that permits immune evasion and long-term persistence. Under host-derived physiological triggers, including inflammatory surges and metabolic stress, biofilm dispersion may expose bacterial products that amplify inflammation and contribute to plaque destabilization. This biofilm-centered framework complements the lipid-centric model by identifying microbial factors as amplifiers of plaque vulnerability. It also highlights potential diagnostic and therapeutic targets aimed at reducing residual inflammatory cardiovascular risk.
No takes yet. Share an insight, caveat, or question.
Hayek et al. (2026) conducted a review in Atherosclerosis and coronary artery disease. Intraplaque microbial biofilms was evaluated on Plaque destabilization and acute coronary events. Intraplaque microbial biofilms act as latent amplifiers of inflammation that promote plaque destabilization and rupture under physiological triggers, complementing the lipid-centric model of CAD.
Synapse has enriched 10 related papers. Consider them for comparative context: